David Statman
- Content Manager, Alliance for Cancer Gene Therapy
Philadelphia
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by David Statman
KIR-CAR Immunotherapy Shows Enhanced Tumor Control in Mesothelioma
The Philadelphia-based biotechnology company Verismo Therapeutics presented preclinical research data that its novel KIR-CAR immunotherapy technology showed enhanced anti-tumor activity in patients with mesothelioma. Verismo unveiled results from a study on Nov. 6, 2026 at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting in Phoenix.
Unrelated to Real Issues
Did this involve sexual harassment? Did it involve grabbing women by their genitals? Did it involve getting women drunk or drugging them with rape drugs and then raping them? If the answer is, “no,” then what is the problem? Was the sexting consensual? Is Platner’s wife aware of it and have they been working out the issues involved? If the answer is. “yes,” then it’s none of our business. kAmpD FDF2=[ E96 ?6HD >65:2[ 6G6?
VIDEO: Obinutuzumab useful for refractory thrombotic thrombocytopenic purpura
Read more You've successfully added Hematology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: Type I protein S deficiency may be linked to venous thromboembolism
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Iberia Romina Sosa, MD, PhD, discusses the results of a study presented at ASH Annual Meeting and Exposition, which examined the risk of thrombosis in patients with a protein S deficiency.
VIDEO: Study examines FLT-3 inhibitors in leukemia treatment
Ask a clinical question and tap into Healio AI's knowledge base. In this video, Catherine Lai, MD, MPH discusses the results of a study presented at ASH Annual Meeting that examined the use of FLT-3 inhibitors in leukemia patients with an FLT-3 mutation.
VIDEO: Some patients can wait for acute myeloid leukemia to start
Source: Healio Interviews Disclosures: Lai reports serving on an advisory board for Astellas, BMS, Daiichi, Genentech and Servier, consulting for AbbVie and Rigel, and receiving research funding from BMS and Jazz.
VIDEO: Menin inhibitors could significantly change leukemia treatment
You've successfully added Leukemia to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Catherine Lai, MD, MPH discusses the results of a study presented at ASH Annual Meeting that examined the use of a new class of menin inhibitors on two different types of mutated acute myeloid leukemia.
VIDEO: Bruton tyrosine kinase inhibitor studied in immune thrombocytopenia
December 24, 2024 5 min watch VIDEO: Bruton tyrosine kinase inhibitor studied in immune thrombocytopenia Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: Major response rate for revumenib in KMT2A acute leukemia
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Daniel DeAngelo, MD, PhD, discusses the results of a study presented at ASH Annual Meeting 2024 that examined the use of menin inhibitors in patients with leukemia.
Q&A: Although preventive mastectomies rise, procedures still not often recommended
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. For many oncologists, the use of mastectomy to treat breast cancer cases can be a difficult subject to approach with patients.
VIDEO: Timdarpacept ‘might have legs’ in chronic myelomonocytic leukemia treatment
October 21, 2024 3 min watch VIDEO: Timdarpacept ‘might have legs’ in chronic myelomonocytic leukemia treatment Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Leukemia . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: Dose expansion study performed on novel BCL-2 inhibitor for acute myeloid leukemia
VIDEO: Dose expansion study performed on novel BCL-2 inhibitor for acute myeloid leukemia In this video, Noah Merin, MD, PhD, discusses the results of a Chinese study into the use of venetoclax in the treatment of acute myeloid leukemia and non-Hodgkin lymphoma, presented at ESMO Congress. Merin, director of the leukemia program at Cedars-Sinai Medical Center, highlighted the study, which was a dose escalation expansion study of a class of drug that AML has already displayed responsiveness to.
VIDEO: New CAR T-cell product may reduce side effects in ALL
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Douglas Tremblay, MD, discusses the results of a study into CD19-targeted chimeric antigen receptor T-cell therapy in acute lymphocytic leukemia presented at ESMO Congress 2024.
VIDEO: Timdarpacept examined in dedicated chronic myelomonocytic leukemia trial
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Douglas Tremblay, MD, discusses the results of a study into a first-line treatment of chronic myelomonocytic leukemia presented at ESMO Congress 2024.
VIDEO: Biomarkers relationship with blood cancers examined at ESMO
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Rosalie Griffin, PhD, discusses the results of a study she presented at ESMO Congress 2024, which examined a biomarker that could indicate a person’s risk for developing blood cancer.
VIDEO: Stopping enzalutamide has little effect on prostate cancer quality of life
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Stephen Freedland, MD, discusses the results of the EMBARK study into high-risk, nonmetastatic biochemically recurrent prostate cancer, which he co-presented at ASCO Annual Meeting.
VIDEO: Asciminib results could yield ‘significant change’ in CML treatment
July 16, 2024 2 min watch VIDEO: Asciminib results could yield ‘significant change’ in CML treatment Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Leukemia . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: TakeAim study produces ‘exciting’ results in mutated acute myeloid leukemia
Read more You've successfully added Leukemia to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Eric Winer, MD, discusses the results of the TakeAim study into acute myeloid leukemia, which he helped present at ASCO Annual Meeting.
VIDEO: Reduced chemotherapy dose decreases toxicity in acute myeloid leukemia
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Eric Winer, MD, discusses the results of research into acute myeloid leukemia presented at ASCO Annual Meeting.
VIDEO: CYCLONE 2 probes abemaciclib and abiraterone in prostate cancer
July 08, 2024 2 min watch VIDEO: CYCLONE 2 probes abemaciclib and abiraterone in prostate cancer Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: Proteolysis-targeting chimeras show promising results in prostate cancer
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Alexander Chehrazi-Raffle, MD, discusses the results of a phase 1/phase 2 study into proteolysis-targeting chimeras in prostate cancer treatment, presented at ASCO Annual Meeting.
VIDEO: A patient’s race/ethnicity affects eligibility for acute myeloid leukemia trials
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Andrew Hantel, MD, discusses the results of a study he helped present at ASCO Annual Meeting on racial disparities in acute myeloid leukemia trials.
VIDEO: Treatment delays do not lead to acute myeloid leukemia survival disparities
June 25, 2024 5 min watch VIDEO: Treatment delays do not lead to acute myeloid leukemia survival disparities Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: Palliative care model increases quality of life for patients with leukemia
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Christine McMahon, MD, discusses the results of a randomized trial of a care model for patients with acute myeloid leukemia and myelodysplastic syndrome, presented at ASCO Annual Meeting.
VIDEO: Study produces ‘impressive’ post-transplant graft-versus-host disease survival rates
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Christine McMahon, MD, discusses the ACCESS study into post-transplant graft-versus-host disease, presented at ASCO Annual Meeting.
VIDEO: Strong results for asciminib in chronic myelogenous leukemia
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Christine McMahon, MD, discusses the results of the phase 3 ASC4FIRST study, pertaining to chronic myelogenous leukemia, presented at ASCO Annual Meeting.
VIDEO: AEGIS II trial probes effect of apolipoprotein A-I on cholesterol
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ATLANTA — In this Healio video exclusive, SethS. Martin, MD,MHS, FAHA, discusses research into lipid disorders from the American College of Cardiology Scientific Session, examining the AEGIS II study on HDL cholesterol.
VIDEO: Olezarsen reduces high triglyceride, ApoC-III levels
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ATLANTA — In this Healio video exclusive, Erica S. Spatz, MD,MHS, discusses research into lipid disorders from the American College of Cardiology Scientific Session, examining studies aimed at reducing high triglycerides.
VIDEO: High-dose risankizumab exhibits promising results for psoriasis in KNOCKOUT study
You've successfully added Psoriasis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into psoriasis from the American Academy of Dermatology Annual Meeting, examining results from the phase 2 KNOCKOUT study.
VIDEO: High-dose risankizumab safe, effective treatment for plaque psoriasis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed psoriasis research from the phase 2 KNOCKOUT study presented at the American Academy of Dermatology Annual Meeting.
VIDEO: Risankizumab ‘easy drug to discuss’ with psoriasis patients
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the interleukin-23 inhibitor risankizumab from the Maui Derm 2024 meeting.
VIDEO: Studies shed further light on guselkumab’s use for psoriasis
Read more You've successfully added Dermatology: Psoriasis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the interleukin-23 inhibitor guselkumab from the Maui Derm 2024 meeting.
VIDEO: Deucravacitinib an ‘exciting’ oral molecule for psoriasis
Read more You've successfully added Dermatology: Psoriasis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the TYK2 inhibitor deucravacitinib from the Maui Derm 2024 meeting, examining its use as a treatment for psoriasis.
VIDEO: Promising data for bimekizumab in psoriasis treatment
You've successfully added Dermatology: Psoriasis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: SPROUT study gives ‘confidence’ in apremilast for pediatric psoriasis
Read more You've successfully added Dermatology: Psoriasis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: Upadacitinib could produce ‘rapid’ improvement in atopic dermatitis
Read more You've successfully added Dermatology: Dermatitis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Raj Chovatiya, MD, PhD, discussed research into the Janus kinase inhibitor upadacitinib from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.
VIDEO: ‘No new safety events’ for abrocitinib in atopic dermatitis
You've successfully added Dermatology: Dermatitis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: Tralokinumab shows long-term improvement in atopic dermatitis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Q&A: Few options exist to watch for, prevent breast cancer recurrence
Read more You've successfully added Hematology Oncology: Breast Cancer to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: Summit trial produces ‘exciting’ data in systemic mastocytosis
Read more You've successfully added Hematology Oncology: Myeloproliferative Neoplasms to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: TRANSFORM-1, MANIFEST-2 herald ‘exciting time’ for myelofibrosis patients
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Lindsay A.M. Rein, MD, discussed the TRANSFORM-1 and MANIFEST-2 trials into combination therapies in myelofibrosis, both of which were presented at the ASH Annual Meeting and Exposition.
Ruxolitinib has positive effect on polycythemia vera symptoms
You've successfully added Hematology Oncology: Myeloproliferative Neoplasms to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Stem-cell treatments prolong OS for blast-phase/accelerated-phase myeloproliferative neoplasms
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Lower platelet count a predictor for ruxolitinib-induced thrombocytopenia
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BET inhibitors combined with JAK inhibitors well-tolerated with myelofibrosis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: RuxoBEAT study probes ruxolitinib therapy in polycythemia vera
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, John Mascarenhas, MD, discussed the RuxoBEAT study into ruxolitinib treatment in patients with polycythemia vera, which was presented at the ASH Annual Meeting and Exposition.
VIDEO: Ruxolitinib plus pelabresib shows promise in MANIFEST-2 study
You've successfully added Hematology Oncology: Myeloproliferative Neoplasms to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VIDEO: TRANSFORM-1, MANIFEST-2 studies probe combo therapies in myelofibrosis
Read more You've successfully added Hematology Oncology: Myeloproliferative Neoplasms to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In this video, Aaron T.
Preliminary data shows lowered cytokine levels in myelofibrosis with PIM1 kinase inhibitor
You've successfully added Hematology Oncology: Myeloproliferative Neoplasms to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Fedratinib shows strong results for previously treated patients with myelofibrosis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with David
Contact David, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack